» Articles » PMID: 33821601

Nanogels with High Loading of Anesthetic Nanocrystals for Extended Duration of Sciatic Nerve Block

Abstract

The development of thermoresponsive nanogels loaded with nanocrystals of the local anesthetic bupivacaine nanocrystals (BNCs) for prolonged peripheral nerve pain relief is reported here. BNCs were prepared using the antisolvent precipitation method from the hydrophobic form of bupivacaine (bupivacaine free base). The as-prepared BNCs were used stand-alone or encapsulated in temperature-responsive poly(ethylene glycol) methyl ether methacrylate (OEGMA)-based nanogels, resulting in bupivacaine NC-loaded nanogels (BNC-nanogels) of monodisperse size. The synthesis protocol has rendered high drug loadings (., 93.8 ± 1.5 and 84.8 ± 1.2 wt % for the NC and BNC-nanogels, respectively) and fast drug dissolution kinetics in the resulting composite material. tests demonstrated the efficacy of the formulation along with an extended duration of sciatic nerve block in murine models of more than 8 h with a formulation containing only 2 mg of the local anesthetic thanks to the thermoresponsive character of the polymer, which, at body temperature, becomes hydrophobic and acts as a diffusion barrier for the encapsulated drug nanocrystals. The hydrophobicity of the encapsulated bupivacaine free base probably facilitates its pass through cell membranes and also binds strongly to their hydrophobic lipid bilayer, thereby protecting molecules from diffusion to extracellular media and to the bloodstream, reducing their clearance. When using BNC-nanogels, the duration of the anesthetic blockage lasted twice as long as compared to the effect of just BNCs or a conventional bupivacaine hydrochloride solution both containing equivalent amounts of the free drug. Results of the tests showed enough sensory nerve block to potentially relieve pain, but still having mobility in the limb, which enables motor function when required. The BNC-nanogels presented minimal toxicity in the study due to their sustained drug release and excellent biocompatibility. The encapsulation of nano-sized crystals of bupivacaine provides a prolonged regional anesthesia with reduced toxicity, which could be advantageous in the management of chronic pain.

Citing Articles

Cationic Curcumin Nanocrystals Liposomes for Improved Oral Bioavailability: Formulation Development, Optimization, In Vitro and In Vivo Evaluation.

Cheng X, Han X, Si J, Dong C, Ji Z, Zhao S Pharmaceutics. 2024; 16(9).

PMID: 39339192 PMC: 11434666. DOI: 10.3390/pharmaceutics16091155.


Comparative study of iontophoresis-assisted transdermal delivery of bupivacaine and lidocaine as anesthetic drugs.

Morarad R, Uerpairojkit K, Chalermkitpanit P, Sirivat A Drug Deliv Transl Res. 2024; 15(2):688-699.

PMID: 38782881 DOI: 10.1007/s13346-024-01627-5.


Degradable Nanogels Based on Poly[Oligo(Ethylene Glycol) Methacrylate] (POEGMA) Derivatives through Thermo-Induced Aggregation of Polymer Chain and Subsequent Chemical Crosslinking.

Filipek K, Otulakowski L, Jelonek K, Utrata-Wesolek A Polymers (Basel). 2024; 16(8).

PMID: 38675081 PMC: 11054481. DOI: 10.3390/polym16081163.


Squalene Loaded Nanoparticles Effectively Protect Hepatic AML12 Cell Lines against Oxidative and Endoplasmic Reticulum Stress in a TXNDC5-Dependent Way.

Bidooki S, Alejo T, Sanchez-Marco J, Martinez-Beamonte R, Abuobeid R, Burillo J Antioxidants (Basel). 2022; 11(3).

PMID: 35326231 PMC: 8945349. DOI: 10.3390/antiox11030581.

References
1.
Thalhammer J, Vladimirova M, Bershadsky B, Strichartz G . Neurologic evaluation of the rat during sciatic nerve block with lidocaine. Anesthesiology. 1995; 82(4):1013-25. DOI: 10.1097/00000542-199504000-00026. View

2.
Dong Y, Ng W, Shen S, Kim S, Tan R . Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation. Int J Pharm. 2009; 375(1-2):84-8. DOI: 10.1016/j.ijpharm.2009.03.013. View

3.
Zhang J, Li S, An F, Liu J, Jin S, Zhang J . Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug release. Nanoscale. 2015; 7(32):13503-10. PMC: 4636738. DOI: 10.1039/c5nr03259h. View

4.
Santamaria C, Woodruff A, Yang R, Kohane D . Drug delivery systems for prolonged duration local anesthesia. Mater Today (Kidlington). 2017; 20(1):22-31. PMC: 5621744. DOI: 10.1016/j.mattod.2016.11.019. View

5.
Lakhani P, Patil A, Wu K, Sweeney C, Tripathi S, Avula B . Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery. Int J Pharm. 2019; 572:118771. PMC: 7323935. DOI: 10.1016/j.ijpharm.2019.118771. View